These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27452651)

  • 21. Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses.
    Barban V; Munoz-Jordan JL; Santiago GA; Mantel N; Girerd Y; Gulia S; Claude JB; Lang J
    Virology; 2012 Aug; 429(2):91-8. PubMed ID: 22542002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.
    Pulendran B
    Nat Rev Immunol; 2009 Oct; 9(10):741-7. PubMed ID: 19763148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incubation periods of Yellow fever virus.
    Johansson MA; Arana-Vizcarrondo N; Biggerstaff BJ; Staples JE
    Am J Trop Med Hyg; 2010 Jul; 83(1):183-8. PubMed ID: 20595499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.
    Querec TD; Pulendran B
    Adv Exp Med Biol; 2007; 590():43-53. PubMed ID: 17191376
    [No Abstract]   [Full Text] [Related]  

  • 25. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
    Guirakhoo F; Arroyo J; Pugachev KV; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Soike K; Ratterree M; Monath TP
    J Virol; 2001 Aug; 75(16):7290-304. PubMed ID: 11462001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DENGUE VACCINES.
    Thisyakorn U; Thisyakorn C
    Southeast Asian J Trop Med Public Health; 2015; 46 Suppl 1():138-45. PubMed ID: 26506740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using recombinant DNA technology for the development of live-attenuated dengue vaccines.
    Lee HC; Butler M; Wu SC
    Enzyme Microb Technol; 2012 Jul; 51(2):67-72. PubMed ID: 22664189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.
    Guy B; Barrere B; Malinowski C; Saville M; Teyssou R; Lang J
    Vaccine; 2011 Sep; 29(42):7229-41. PubMed ID: 21745521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
    Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
    PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multi-Perspective Review on Dengue Research.
    Sobhia ME; Ghosh K; Singh A; Sul K; Singh M; Kumar R; Sandeep ; Merugu S; Donempudi S
    Curr Drug Targets; 2019; 20(15):1550-1562. PubMed ID: 31339068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.
    Juan-Giner A; Warimwe G
    Lancet Infect Dis; 2024 Jun; 24(6):562-564. PubMed ID: 38335975
    [No Abstract]   [Full Text] [Related]  

  • 35. An inactivated cell-culture vaccine against yellow fever.
    Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
    N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and laboratory features of dengue virus-infected travellers previously vaccinated against yellow fever.
    Teichmann D; Göbels K; Niedrig M; Grobusch MP
    Scand J Infect Dis; 2003; 35(6-7):427-9. PubMed ID: 12953964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.
    Mantel N; Girerd Y; Geny C; Bernard I; Pontvianne J; Lang J; Barban V
    Vaccine; 2011 Sep; 29(38):6629-35. PubMed ID: 21745519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of yellow fever virus whole genome from an individual with severe vaccine-associated viscerotropic disease.
    Walker HN; Caly L; Savic I; Aziz A; Tran T; Whitley M; Chavada R; Lim CK
    Lancet Microbe; 2024 May; 5(5):e414. PubMed ID: 38219755
    [No Abstract]   [Full Text] [Related]  

  • 39. [Reflection on 2 current viral diseases: yellow fever and dengue].
    Chastel C
    Ann Biol Clin (Paris); 1997; 55(5):415-24. PubMed ID: 9347008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
    Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
    Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.